Because of the many possible etiologic factors involved in female sexual dysfunction and the variability in the response to existing treatment modalities, this area requires research to develop new safe and effective therapeutic alternatives. As one possible strategy, a variety of materials have been injected in the periurethral area to treat both sexual dysfunction and urinary incontinence. the injection of hyaluronic acid fillers (the “G-Shot”) has been used as a treatment to enhance orgasmic intensity by the amplification of a controversial anatomical area in the anterior vaginal wall (the Graffian Spot). Due to the potential incidence of granuloma formation by hyaluronic acid fillers at the injection site, this therapy has been condemned by the American College of Obstetrics and Gynecology.
Some cases of female sexual dysfunction, manifested by decreases in sexual desire, arousal, lubrication and orgasmic responsiveness, may be treated with specifically directed injections of autologous Platelet Rich Plasma (PRP) in the area of the Skene’s glands and the clitoris. The issue of female sexual dysfunction is quite common. Data shows that sexual difficulties may be experienced by more than 40% of the sexually active adult female population at some time in their lives.
The O-Shot® can help:
Decreased libido (sex drive)
Stress urinary incontinence
Dryness (with resulting painful intercourse) from Menopause or from Breast Cancer Treatment
Decreased ability to orgasm
Urge urinary incontinence
Postpartum fecal incontinence
Chronic pain from trauma from child birth (episiotomy scars)
Chronic pain from mesh
Chronic interstitial cystitis